Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells - PubMed (original) (raw)
Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells
Dong Yeok Shin et al. Biomed Pharmacother. 2013 May.
Abstract
Decitabine (5-aza-2'-deoxycytidine), an inhibitor of DNA methyltransferases, has a wide range of anti-metabolic and anti-cancer activities. Decitabine also induces cell cycle arrest at G2/M phase and apoptosis in human cancer cells. However, the cellular and molecular mechanisms of this cell cycle arrest are poorly understood. In the present study, we investigated the roles of the tumor suppressor p53 and the cyclin-dependent kinase (Cdk) inhibitor p21 following decitabine-induced G2/M arrest in human cancer cells. DNA flow cytometric analyses indicated that decitabine induced a G2/M arrest in AGS gastric and A549 lung carcinoma cell lines, which have wild type p53. Western blot analyses using whole cell lysates from AGS cells demonstrated that decitabine treatment did not change the steady-state level of Cdks and Cdk inhibitor p27, but it partially inhibited expression of cyclin A, cyclin B1, and Cdc25C proteins. However, similar results were found using the A549 cell line, where decitabine induced a dramatic up-regulation of both p53 and p21 expression, and the increased levels of p21 were associated with increased binding of p21 with Cdks, cyclin A, and cyclin B1. Knockdown of p53 by small interfering RNA (siRNA) markedly abolished p53 induction by decitabine in AGS cells, yet p53 siRNA had no attenuating effect on p21 induction. In addition, depletion of p21 expression with siRNA, but not p53, significantly attenuated decitabine-induced G2/M arrest. We also observed that decitabine strongly induced G2/M arrest associated with p21 induction in both p53 allele-null (-/-) HCT116 and wild type p53 (+/+) HCT116 cell lines. Therefore, our data indicated that p21 plays a crucial role in decitabine-induced G2/M arrest and operates in a p53-independent manner.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.
Similar articles
- TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J, Kim S, Yang JH, Nam SJ, Lee JE. Han J, et al. Oncol Rep. 2012 Feb;27(2):517-22. doi: 10.3892/or.2011.1511. Epub 2011 Oct 20. Oncol Rep. 2012. PMID: 22020547 - Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells.
Cho JH, Lee JG, Yang YI, Kim JH, Ahn JH, Baek NI, Lee KT, Choi JH. Cho JH, et al. Food Chem Toxicol. 2011 Aug;49(8):1737-44. doi: 10.1016/j.fct.2011.04.019. Epub 2011 Apr 29. Food Chem Toxicol. 2011. PMID: 21554918 - Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng P, Zhao S, Chen M, Yang G, He G. Liu Y, et al. Eur J Pharmacol. 2013 Jan 5;698(1-3):95-102. doi: 10.1016/j.ejphar.2012.10.013. Epub 2012 Oct 29. Eur J Pharmacol. 2013. PMID: 23117090 - TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK. Lim IK. J Cancer Res Clin Oncol. 2006 Jul;132(7):417-26. doi: 10.1007/s00432-006-0080-1. Epub 2006 Feb 3. J Cancer Res Clin Oncol. 2006. PMID: 16456675 Review. - CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication.
Mansilla SF, de la Vega MB, Calzetta NL, Siri SO, Gottifredi V. Mansilla SF, et al. Genes (Basel). 2020 May 28;11(6):593. doi: 10.3390/genes11060593. Genes (Basel). 2020. PMID: 32481484 Free PMC article. Review.
Cited by
- Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.
Hoang NM, Liu Y, Bates PD, Heaton AR, Lopez AF, Liu P, Zhu F, Chen R, Kondapelli A, Zhang X, Selberg PE, Ngo VN, Skala MC, Capitini CM, Rui L. Hoang NM, et al. Cell Rep Med. 2024 Apr 16;5(4):101484. doi: 10.1016/j.xcrm.2024.101484. Epub 2024 Mar 29. Cell Rep Med. 2024. PMID: 38554704 Free PMC article. - TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion.
Eisenmann ED, Stromatt JC, Fobare S, Huang KM, Buelow DR, Orwick S, Jeon JY, Weber RH, Larsen B, Mims AS, Hertlein E, Byrd JC, Baker SD. Eisenmann ED, et al. Cancers (Basel). 2022 Dec 21;15(1):29. doi: 10.3390/cancers15010029. Cancers (Basel). 2022. PMID: 36612026 Free PMC article. - Drug Repurposing Applications to Overcome Male Predominance via Targeting G2/M Checkpoint in Human Esophageal Squamous Cell Carcinoma.
Yin Y, Yu X, Feng R, Li Y, Zhao Y, Liu Z. Yin Y, et al. Cancers (Basel). 2022 Nov 28;14(23):5854. doi: 10.3390/cancers14235854. Cancers (Basel). 2022. PMID: 36497337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous